Radio Rare

Radio Rare

By Rare Cancers AustraliaBusinessNon-Profit
Download on the App Store

Radio Rare episodes

  • Thought Leader Series: Our responsibility to patients who can’t afford to wait, Professor John Zalcberg

    Professor John Zalcberg

    Head, Cancer Research Program, School of Public Health, Monash University
     
    Our responsibility to patients who can’t afford to wait

    In this episode, RCA Chief Executive Richard Vines speaks to Professor John Zalcberg about:
    - How he was destinated to be in medicine since childhood
    - Why he chose to specialise in cancer care
    - The challenges around making clinical trials more ‘ambitious’
    - How wealth impacts your access to cancer drugs in Australia
    - How the cost of drugs to the community trumps urgent provision to patients
    - The challenges of working within the current health system
    - Ideas to help speed up critical access to treatment
    - The untapped potential of patient data

    More about Professor John Zalcberg
    John was Director of Cancer Medicine at the Peter MacCallum Cancer Centre for 17 years, as well as their Chief Medical Officer for six. He is highly regarded both nationally and internationally as a leader in his field, is a mentor to some of the most accomplished clinicians in Australia, and is a well-known advocate for patient access to new cancer drugs.  

    #thoughtleaderseries

    33 min
  • Thought Leader Series: Risks and rewards: getting new medications into the hands of patients, Carlo Montagner

    Carlo Montagner

    Co-Founder and CEO, Specialised Therapeutics Australia

    Risks and rewards: getting new medications into the hands of patients

    In this episode, RCA Chief Executive Richard Vines speaks to Carlo Montagner about: 

    • His move from psychology to pharma
    • Building a strong foundation in the industry
    • Founding STA with his wife
    • The barriers to, and costs of, supplying drugs in Australia
    • How the process can be improved and simplified
    • Accessing drugs not listed on the PBS
    • The responsibility of clinicians around reimbursement
    • The challenges and opportunities of Health Technology Assessment (HTA)
    • Why STA is expanding into Asia
    • His family’s personal experience with rare cancer
    • Why he is passionate about bringing rare cancer drugs to Australia
    • His vision for the future  

      • More about Carlo Montagner: Specialised Therapeutics Australia (STA) is a pharmaceutical company that has been instrumental in helping Australians living with rare cancer to access new medications that would otherwise be out of reach. Before co-founding STA, Carlo held senior roles at some of the world’s largest pharmaceutical companies.  #thoughtleaderseries

      35 min
    • Thought Leader Series: From Registered Nurse to Chief Executive, Professor Shelley Dolan
      Professor Shelley Dolan
      Chief Executive, Peter MacCallum Cancer Centre
      From Registered Nurse to Chief Executive

      In this episode, RCA Chief Executive Richard Vines speaks to Professor Shelley Dolan about:

      • Signing up as a nurse dressed in full punk rock gear, complete with pink hair
      • Her love of intensive care and why she moved to cancer care
      • Moving up the ranks from nurse to CEO
      • What she’s learned, and continues to learn, from patients and their families
      • Making your voice heard as a patient
      • The challenges of being a nurse – and a woman – in a patriarchal system
      • How Peter Mac works, access to drugs, and why it’s such a special place
      • How we can improve access to clinical trials in rural and regional areas
      • Her vision for the future
        • More about Professor Shelley Dolan

        Shelley began her career as a registered nurse in the UK, rising through the ranks to become Deputy Chief Executive at one of the largest hospitals in Europe and also at Europe’s largest comprehensive cancer centre.

        She has over 30 years of experience in healthcare, specialising in critical care and cancer nursing.

        28 min
      • COVID Connect: COVID-19 Vaccine Research with Prof Rhonda Stuart
        We are living in extraordinary times, and uncertainty drives us to seek answers. It's easy to get swept away in a sea of conflicting information.
        In the latest episode of Radio Rare in our COVID Connect mini-series, we go back to basics with Professor Rhonda Stuart from Monash Health. Drawing on her extensive career in public health, she explains how the COVID-19 virus operates, how the vaccines work, and how both of these things can effect people living with cancer.
        24 min
      • COVID Connect: Impact of COVID-19 on our healthcare system, with Dr Nick Pavlakis and Geraldine McDonald
        The impact of COVID-19 on our healthcare system has and continues to be significant.
        In our latest episode of Radio Rare in our COVID Connect mini-series, we take you into the hospital world and explore the NSW and Victorian experiences through the lens of two experts - Oncologist at Royal North Shore Hospital, Prof Nick Pavlakis and Director of Prevention and Wellbeing at the Peter MacCallum Cancer Centre, Geraldine McDonald.
        43 min
      • COVID Connect: Adjusting to a new normal with Maddie
        It was just before Melbourne's second lockdown (lasting 111 days) that Maddie was diagnosed with thymoma.
        In our first Radio Rare episode in our COVID Connect mini-series, she shares how she adjusted to her new normal - facing not just a cancer diagnosis, but the added uncertainty of a rare cancer diagnosis in a global pandemic.
        39 min

      About Radio Rare

      From the publisher's feed

      Radio Rare is a podcast where we share the stories of those in and around the rare and less common cancer community.

      More shows like Radio Rare

      Bronwyn by The Australian

      Bronwyn

      301 Listeners